BioSpace News Archive

Boston Scientific (NYSE: BSX) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for single-use duodenoscopes, applicable to the EXALT™ Model D Single-Use Duodenoscope, as part of its Fiscal Year 2022 Hospital Inpatient Prospective Payment System.

TAAG Genetics announced today that its TAAG F41 VIP kit, a multiplex real-time PCR assay capable of detecting four separate foodborne pathogens in a single reaction, has been granted Performance Tested MethodsSM status from the AOAC Research Institute (certification #072101).

Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations & corporate communications, will participate in 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

Jacobio Pharmaceuticals (1167.HK) today announced the first patient was dosed in a Phase I/II clinical trial of KRAS G12C inhibitor JAB-21822 in China.

SCYNEXIS, Inc., a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, announced grants of stock options to five new employees to purchase an aggregate of 24,500 shares of SCYNEXIS common stock at a per share exercise price of $6.97, the closing trading price on July 30, 2021.

PharmaCyte Biotech, Inc. (OTCQB: PMCBD) (PharmaCyte or Company), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that The Nasdaq Stock Market LLC (Nasdaq) has approved the listing of the Company’s common stock on Nasdaq.

TriLink BioTechnologies has enabled Chula Vaccine Research Center, at the Faculty of Medicine, Chulalongkorn University, Bangkok, to deliver an mRNA Covid-19 vaccine that has been approved for an immediate FIH phase 1 clinical trial in Thailand.

CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, today announced the appointment of Shaun Blakeman as the company’s Chief Financial Officer.

Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, will release financial results for the period ending June 30, 2021 on Tuesday, August 3, 2021 before the market opens, followed by a conference call.

Resonant Inc. will release financial results for the second quarter ended June 30 th , 2021 after market close on Wednesday, August 11 th , 2021.